Cell and Gene Therapy Market Scenario | DelveInsight
Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL)
pharma-news-updates-for-biomarin-gilead-alzheon
FDA rejects BioMarin’s Valoctoc...

FDA rejects BioMarin's gene therapy and Gilead's filgotinib over concerns The FDA refused to approve BioMar...

pharma-news
Startup focuses tumors with CAR-T; Ab...

The startup focuses on glioblastoma tumors with CAR-T therapy. CAR-T technology that involves genetically m...

pharma-news
CanSino deals with Precision; Atea ra...

CanSino adds mRNA with Precision NanoSystems  CanSino Biologics is already evaluating a recombinant co...

CAR-T cell therapy market for Non-Hodgkin lymphoma
CAR-T cell therapy market for Non-Hodgkin lymphoma: Future prospects, and untapped opportunities

As per DelveInsight, the CAR T-Cell Therapy Market size for Non-Hodgkin lymphoma in the 6MM (the US, EU5 (the UK, Germany, France, Italy and Spain)) is expected to be USD 2796.2 Million by 2030....


CAR-T Cell Therapy Market In ALL- Acute lymphocytic leukemia
Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL)

DelveInsight estimates by 2030, the Car-T cell therapy market in Acute lymphoblastic leukaemia would approximate to USD 1,315.7 million in the 6MM (U.S. and EU5 including UK, Germany, Italy, Fran...


Pharma News
CAR-T in killing tumors; Amunix raises $73M; Autism findings in protein-targeted treatment

Killing brain tumors with the help of CAR-TCAR-T cell therapy is a technique which involves modifying patients' T cells to aim proteins associated with cancer that have revolutionized some of ...


cocaine addiction
Gene therapy might make cocaine less addictive

Cocaine- a stimulant- made from the most addictive plant - cocoa plant, is known as the most addictive substance known to be existing on the Earth, hence is abused the most. As per the annual repo...


Car-TCR Summit Europe 2020
Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?

The third edition of CAR-TCR Summit Europe is a one-stop platform that provides attendees with a holistic view of the Gene therapy market, listing the solutions to the plausible hurdles that come ...


Curing HIV with gene therapy
In a blind race to cure HIV, can Gene therapy be a deal-breaker?

HIV infection has become a global health burden, has claimed over 32 million lives so far since the very first case of AIDS was reported in 1981. According to a report put forward by the WHO, HIV ...


Cocaine Use Disorder Market
Cocaine Use Disorder...

Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....

Cardiovascular Disease Devices Whitepaper
Cardiovascular Disease De...

Today, the sedentary lifestyle adopted among people has led to cause a myriad of underlying diseases.....

Lupus Nephritis Market
Lupus Nephritis...

Lupus Nephritis (LN) is one of the most common manifestations of systemic lupus erythematosus (SLE),.....

Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...